DISURINORM®

faq

The risk factors for benign prostatic enlargement (BPH) include many factors, including age, obesity, metabolic disorders, family history of the disease, lifestyle.

Your excretory symptoms may indicate that you have a benign prostate: Waiting for urination, straining, straining, interrupted urination, Post-urinary symptoms: Inability to fully empty your urine, feeling of urinary retention in the bladder, dripping after urinating.

The prostate is a gland located in the lower urinary tract, at the bottom of the bladder (bladder), around the urethra (urinary canal located at the exit of the bladder). A healthy prostate is about the size of a large walnut and has a volume of 15-25ml.​

Factors that cause benign prostatic enlargement are age, family history of the disease, metabolic syndrome, heart attack, and lifestyle. Click here for detailed information.​

Numerous studies have confirmed that prostate volume is an important predictor of the progression of prostate adenoma. It has been observed that the prostate is higher than 30 ml in men with BPH.​

Disurinorm® is a product formulated in Spain and developed by Setonda® Laboratories. The entire production process is being completed in Spain.
While existing treatments are not suitable for long-term use because they cause many side effects, Disurinorm® has been prepared for use at all stages of BPH, including the wait-and-see period with its side effect feature.
It is recommended to use Disurinorm® Advance Suspension 250 ml form 10 ml 2 times after meals. It is recommended to use Disurinorm® 30 Capsules form 1 capsules 2 times after meals. More Info

No side effects were observed in any age.